Skip to main content
Back to News

News From Around the System

Reversing Cancer’s Gluttony

UC San Diego Health — May 12, 2022

Researchers at UC San Diego School of Medicine and Moores Cancer Center describe how pancreatic cancer cells use an alternative method to find necessary nutrients, defying current therapies, to help them grow and spread.

Rethinking Remdesivir

UC San Diego Health — May 12, 2022

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

UC San Diego Researchers Convert Pro-Tumor Macrophages into Cancer Killers

UC San Diego Health — May 12, 2022

University of California San Diego School of Medicine researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts